Novavax and our partner SK bioscience are pleased to announce our protein-based #COVID19Vaccine has been approved for adolescents ages 12-17 in South Korea. Learn more here: bit.ly/3QIfBSr pic.twitter.com/oMAHJ354Uf

13 likes, 1 retweet
Novavax on Twitter